BTK and B-cell chronic lymphocytic leukemia: More recently, a study on primary CLL cells and cell lines also showed that treating cells with iron in combination with Bruton’s tyrosine kinase (Btk) inhibitor, ibrutinib or the BCL-2 inhibitor, venetoclax, led to a significant accumulation of MDA and death of leukemic, but not healthy, cells [123].